Developer docs
API playgroundTry for free, no card

Search company profiles

Sejong Medical

Full company profile

uuid000zmzq

Namestring
Sejong Medical
Legal namestring
주식회사 세종메디칼 (Sejong Medical Co., Ltd.)
Company typeenum
Public
Founded yearint
1996
Descriptiontext

Sejong Medical Co., Ltd. (주식회사 세종메디칼) is a South Korean medical device manufacturer specializing in disposable laparoscopic surgical instruments, founded in 1996 in Paju, Gyeonggi-do. The company developed Korea's first domestically produced trocar in October 1996 and has since built a comprehensive portfolio spanning trocars (Laport series), single-port access devices (Lapsingle family including Da Vinci-compatible variants), specimen retrieval pouches (Lapbag, Dropbag), absorbable suture loops (Laploop), suction/irrigation electrodes (LAP-iX, LAP-iX2), smoke filtration systems (Smoklean), and uterine manipulators (BUMI). Manufacturing operates under a 100% in-house "One Stop Production System" covering R&D, assembly, packaging, and sterilization, supported by registered Korean and US patents across core product lines and full regulatory clearances including FDA 21 CFR Part 11, CE, ISO 13485, and Korean MFDS GMP certifications (acquired 2007).

The company's revenue model is hardware sales of disposable devices to hospitals and surgical centers performing minimally invasive surgery, with direct field sales domestically (Korea) and distributor-based international sales across Europe (Medica Germany), the Middle East (WHX Dubai), and other CE/FDA-cleared export markets. Customer segments are horizontal — general surgery, gynecology, urology, and gastrointestinal — with international distributors serving as the secondary GTM channel alongside enterprise hospital sales.

Sejong Medical was KOSDAQ-listed in May 2018 but entered a period of significant corporate restructuring in 2025-2026: shareholders passed a dissolution resolution on December 31, 2025; the Korea Exchange issued a delisting decision on June 11, 2026; and major shareholder BSJ Holdings conducted a competitive tender sale of its 31.43% stake and 40B KRW convertible bonds (up to 55.1% fully diluted) through Samil KPMG Deal Advisory. Financial performance has been challenged, with revenue declining from a 2021 peak and net losses persisting through 2025, despite export award progression ($1M → $2M → $3M tiers) and continued product launches.

Short descriptiontext

Sejong Medical is a Korean medical device manufacturer founded in 1996 that develops, produces, and sells disposable laparoscopic surgical instruments — including trocars, single-port systems, specimen pouches, and electrosurgery devices — to hospitals and surgical centers domestically and via international distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPaju, South Korea
HQ citystring
Paju
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
laparoscopic surgical instruments, single port access devices, minimally invasive surgery devices, disposable trocar devices, surgical smoke filtration
Industry4 codes
1Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
CodeHLAHADAAPrimaryYes
2Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
CodeHLAHADANPrimaryNo
3Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
CodeHLAHADAMPrimaryNo
4Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)
CodeHLAKAJAFPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Laparoscopic Surgical Instruments / Minimally Invasive Surgery Devices
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Sejong Medical generates revenue primarily from the manufacture and sale of laparoscopic surgical instruments and medical devices, including trocars, single-port systems, suction/irrigation devices, smoke filters, specimen retrieval pouches, suture loops, and uterine manipulators. Products are sold through direct sales to hospitals and channel distributors internationally.

sejongmedical.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Laport
Description

Disposable trocar product line including Laport-S, Laport-U, Laport-MU, Laport-e, Laport-3, Laport-CS models

sejongmedical.com
+7 more records
Core offering1 text field

Sejong Medical develops, manufactures, and sells laparoscopic surgical instruments for minimally invasive surgery, including trocars (Laport series), single-port access systems (Lapsingle), specimen retrieval pouches (Lapbag, Dropbag), suture loops (Laploop), suction/irrigation electrodes (LAP-iX), smoke filters (Smoklean), and uterine manipulators (BUMI). All products are manufactured in-house through a 100% one-stop production system covering R&D, manufacturing, packaging, and sterilization, and are sold to hospitals, surgical centers, and international distributors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Laparoscopic surgery reduces recovery time to 5–10 days compared to 6–8 weeks for open surgery
+2 more records
Product overview1 text field

Sejong Medical is a Korean medical device company specializing in laparoscopic surgical instruments, established in 1996 and recognized as a leader in Korea's laparoscopic medical device market. The company operates a One Stop production system covering in-house development, manufacturing, packaging, and sterilization. The product portfolio centers on laparoscopic surgery equipment organized into six main categories: Trocars (Laport series including Laport-S, Laport-U, Laport-MU, Laport-e, Laport-3, DRG Port, Hiport, Mini Port, and Laport-CS for thoracoscopy), Single Port Access Devices (Lapsingle, Lapsingle Plus, Lapsingle Vision, Lapsingle SP for Da Vinci robotic surgery, Search Port, and Wound Retractor), Specimen Retrieval Pouches (Lapbag and Dropbag), Suture Loop Devices (Laploop), Suction Irrigation Electrode Devices (LAP-iX series including LAP-iX2), and Smoke Filters (Smoklean). Additional specialized products include BUMI for uterine manipulation during hysterectomy. The company exports globally and holds international certifications including FDA, CE, ISO 13485, and Korean GMP.

Product and service23 records
1Laport-S
CategoryTrocar / Disposable Laparoscopic Trocar
Description

A trocar device that maintains pneumoperitoneum and enables insertion of various laparoscopic surgical instruments through the abdominal wall. Features a rotatable 5mm converter for dual-spec use, one-touch button for smoke and gauze removal, serration structure preventing insertion device detachment, and blade-type secondary puncture prevention. Used by surgeons performing laparoscopic surgery.

2Laport-U (Universal)
CategoryTrocar / Disposable Laparoscopic Trocar
Description

Universal trocar allowing insertion of various-sized instruments. Features blade-type stable locking mechanism preventing secondary puncture and round head structure for comfortable grip. Used by surgeons performing laparoscopic surgery.

3Laport-MU (Mini Universal)
CategoryTrocar / Disposable Laparoscopic Trocar
Description

Mini universal trocar with safety lock and auto loading for secondary puncture prevention. Accommodates instruments from 5mm to 12mm. Features detachable head for easy gauze and specimen removal, serration structure preventing detachment, and 30% smaller head than standard Laport for improved grip and reduced port interference. Used by surgeons performing laparoscopic surgery.

4DRG Port
CategoryTrocar / Disposable Laparoscopic Trocar
Description

Trocar with manual locking and release mechanism with indicator. Features 40% smaller simplified head design compared to previous models and cross-shaped sealing valve. Used by surgeons performing laparoscopic surgery.

5Laport-e
CategoryTrocar / Disposable Laparoscopic Trocar
Description

Trocar featuring ergonomic design that provides excellent grip comfort for surgeons during laparoscopic surgery.

6Hiport
CategoryTrocar / Disposable Laparoscopic Trocar
Description

Trocar equipped with rotatable 5mm converter for dual-spec use. Used by surgeons performing laparoscopic surgery.

7Mini Port
CategoryTrocar / Disposable Laparoscopic Trocar
Description

Small-sized trocar designed for pediatric or petite patients requiring smaller instrumentation. Used by surgeons performing laparoscopic surgery.

8Laport-3
CategoryTrocar / Disposable Laparoscopic Trocar
Description

Trocar made of high-durability stainless steel, designed for 2–3mm instruments with minimized body and outer surface providing excellent grip. Used by surgeons performing laparoscopic surgery.

9Laport-CS
CategoryTrocar / Thoracoscopic Trocar
Description

Trocar consisting of cannula and stylet for thoracic endoscopic surgery. Features serrated cannula for easy insertion and increased port stability with reduced slippage. Available in Hard Type for strong impact resistance and Soft Type with flexible material reducing tissue and chest pressure. Used by surgeons performing thoracoscopic surgery.

10Lapsingle
CategorySingle Port Access Device
Description

Versatile single port for all types of single-port laparoscopic surgery including robotic surgery. Features separable single-port design for single incision surgery, universal port accommodating instruments from 5mm to 12mm, and spring valve ensuring smooth gas circulation. Used by surgeons performing single-incision laparoscopic surgery.

11Lapsingle Plus
CategorySingle Port Access Device
Description

Single port device with spring valve for smooth gas circulation and optimized for robotic surgery with high flexibility and heat resistance. Used by surgeons performing robotic-assisted laparoscopic surgery.

12Lapsingle Vision
CategorySingle Port Access Device
Description

Single port device with high transparency for enhanced visualization during laparoscopic procedures. Used by surgeons performing single-port laparoscopic surgery.

13Lapsingle SP
CategorySingle Port Access Device (Da Vinci)
Description

Da Vinci robotic surgery single-port laparoscopic device featuring Davinci SP Port (25mm) with transparent material for easy abdominal access. Used by surgeons performing Da Vinci robotic-assisted surgery.

14Search Port
CategorySingle Port Access Device
Description

Port primarily used during laparoscopic examination, featuring flexible material allowing easy scope manipulation through the port. Used by surgeons during laparoscopic examination procedures.

15Wound Retractor
CategorySingle Port Access Device Accessory
Description

Device serving as passage for Lapsingle products, used to protect skin and facilitate easier incision opening. Features high durability of urethane material and provides easy and stable incision space. Used by surgeons performing single-port laparoscopic surgery.

16Lapbag
CategorySpecimen Retrieval Pouch
Description

Specialized bag for safely extracting various specimen tissues generated during laparoscopic surgery. Features automatic pouch operation, multiple sizes (XS, S, M, L, XL, XXL, 3XL), multiple types (U Type, V Type, Y Type), and sturdy durability. Used by surgeons performing laparoscopic surgery.

17Dropbag
CategorySpecimen Retrieval Pouch
Description

Easy-opening specimen retrieval pouch with pre-folded design for easy handling. Features tear-resistant sturdy material pouch and dual welt cores preventing separation of pouch fixation device. Used by surgeons performing laparoscopic surgery.

18Laploop
CategorySuture Loop Device
Description

Device for suturing wounds with convenient usage method. Features absorbable suture material that is harmless to the body and stable knot that does not come undone. Used by surgeons performing wound closure during laparoscopic surgery.

19LAP-iX S/I only
CategorySuction Irrigation Device
Description

Suction and irrigation device for laparoscopic surgery with shaft size of 5mm and shaft lengths of 330mm and 450mm. Used by surgeons performing laparoscopic surgery.

20LAP-iX
CategorySuction Irrigation Electrode Device
Description

Suction and irrigation device with electrode for various uses during laparoscopic surgery. Features 5mm shaft, separable tip and handle design. Used by surgeons performing laparoscopic surgery.

21LAP-iX2
CategorySuction Irrigation Electrode Device
Description

Improved suction and irrigation device with electrode featuring enhanced electrode tip that reduces likelihood of carbonized material adhering to end and easier removal. Features ergonomic handle with anti-slip bushing for excellent grip and smooth S/I control with soft button minimizing user fatigue. Used by surgeons performing laparoscopic surgery.

22Smoklean
CategorySmoke Filter / Exhaust Filter
Description

Filter device that removes harmful particles and substances from exhaust gas generated when using energy devices during laparoscopic surgery. Effectively reduces smoke and color. Features PRE/ACF/DNA filters that filter out carcinogens and smoke. Used by surgical teams during laparoscopic surgery to filter surgical smoke.

23BUMI
CategoryUterine Manipulator / Positioner
Description

Device used during laparoscopic hysterectomy to adjust uterine position. Features ergonomic handle for user comfort during long surgeries, automatic valve preventing air leakage after inflation, tip with surgical cutting guide line and rotatable handle for cup angle adjustment, and 1mm thick round tip providing sufficient strength. Used by gynecologic surgeons performing laparoscopic hysterectomy.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-10-01
Description

KPMG Korea's Deal Advisory division (Samil) served as M&A advisor and sale process manager for the competitive tender sale of BSJ Holdings' stake in Sejong Medical. Managing directors Bong-soo Kim and Se-hun Kim oversaw the process, managing bidder qualification, due diligence data rooms, and bidding coordination.

2Local Distributors (International)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Sejong Medical forms strategic partnerships with local distributors in overseas markets to expand its global footprint. These distributors facilitate local market entry, regulatory navigation, and sales distribution for Sejong's laparoscopic devices across multiple international markets.

sejongmedical.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sejong Medical collaborates with international medical institutions to support product adoption, gather clinical feedback, and tailor products to regional medical practices and surgical technique requirements.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers6 records
TypeBroad incumbent
TypeDirect peer
Description

Karl Storz is a leading German manufacturer of endoscopes and laparoscopic instruments for minimally invasive surgery. Direct competitor to Sejong across the laparoscopic instrument category, with global distribution overlap including Europe and the Middle East.

TypeBroad incumbent
Description

Ethicon is the surgical instruments arm of Johnson & Johnson and a dominant global supplier of trocars, staplers, sutures, and other laparoscopic devices. Operates broadly across all surgical specialties served by Sejong, with vastly larger scale.

TypeBroad incumbent
Description

Medtronic's Minimally Invasive Therapies group (including legacy Covidien) is a leading global supplier of laparoscopic instruments, energy devices, and surgical supplies. Broad incumbent with substantial overlap with Sejong's product categories.

TypeDirect peer
Description

Applied Medical is a US-based privately held manufacturer of surgical devices including trocars, single-port access systems, and other laparoscopic instruments — directly overlapping Sejong Medical's core trocar (Laport) and single-port (Lapsingle) product lines.

TypeBroad incumbent
Description

Olympus is a global leader in endoscopic visualization and minimally invasive surgical instruments. While strongest in scopes, Olympus also supplies trocars and laparoscopic accessories that overlap with Sejong's portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sejong Medical

Laparoscopic Surgical Instruments / Minimally Invasive Surgery Devicessejongmedical.com

Sejong Medical is a Korean medical device manufacturer founded in 1996 that develops, produces, and sells disposable laparoscopic surgical instruments — including trocars, single-port systems, specimen pouches, and electrosurgery devices — to hospitals and surgical centers domestically and via international distributors.

What Sejong Medical does

Sejong Medical Co., Ltd. (주식회사 세종메디칼) is a South Korean medical device manufacturer specializing in disposable laparoscopic surgical instruments, founded in 1996 in Paju, Gyeonggi-do. The company developed Korea's first domestically produced trocar in October 1996 and has since built a comprehensive portfolio spanning trocars (Laport series), single-port access devices (Lapsingle family including Da Vinci-compatible variants), specimen retrieval pouches (Lapbag, Dropbag), absorbable suture loops (Laploop), suction/irrigation electrodes (LAP-iX, LAP-iX2), smoke filtration systems (Smoklean), and uterine manipulators (BUMI). Manufacturing operates under a 100% in-house "One Stop Production System" covering R&D, assembly, packaging, and sterilization, supported by registered Korean and US patents across core product lines and full regulatory clearances including FDA 21 CFR Part 11, CE, ISO 13485, and Korean MFDS GMP certifications (acquired 2007).

The company's revenue model is hardware sales of disposable devices to hospitals and surgical centers performing minimally invasive surgery, with direct field sales domestically (Korea) and distributor-based international sales across Europe (Medica Germany), the Middle East (WHX Dubai), and other CE/FDA-cleared export markets. Customer segments are horizontal — general surgery, gynecology, urology, and gastrointestinal — with international distributors serving as the secondary GTM channel alongside enterprise hospital sales.

Sejong Medical was KOSDAQ-listed in May 2018 but entered a period of significant corporate restructuring in 2025-2026: shareholders passed a dissolution resolution on December 31, 2025; the Korea Exchange issued a delisting decision on June 11, 2026; and major shareholder BSJ Holdings conducted a competitive tender sale of its 31.43% stake and 40B KRW convertible bonds (up to 55.1% fully diluted) through Samil KPMG Deal Advisory. Financial performance has been challenged, with revenue declining from a 2021 peak and net losses persisting through 2025, despite export award progression ($1M → $2M → $3M tiers) and continued product launches.

Sejong Medical firmographics

Firmographics
Name
Sejong Medical
Legal name
주식회사 세종메디칼 (Sejong Medical Co., Ltd.)
Website
https://sejongmedical.com
Company type
Public
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
Sejong Medical is a Korean medical device manufacturer founded in 1996 that develops, produces, and sells disposable laparoscopic surgical instruments — including trocars, single-port systems, specimen pouches, and electrosurgery devices — to hospitals and surgical centers domestically and via international distributors.
Ownership category
akta.pro rank

Sejong Medical industry classification

Industry
Product category
Laparoscopic Surgical Instruments / Minimally Invasive Surgery Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
akta.pro secondary industries
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF)

Keywords

  • Laparoscopic surgical instruments
  • Single port access devices
  • Minimally invasive surgery devices
  • Disposable trocar devices
  • Surgical smoke filtration

Where Sejong Medical is headquartered

Location

Headquarters

HQ city
Paju
HQ country
South Korea
HQ region
Asia

Offices2 records

Markets served

Sejong Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Sejong Medical generates revenue primarily from the manufacture and sale of laparoscopic surgical instruments and medical devices, including trocars, single-port systems, suction/irrigation devices, smoke filters, specimen retrieval pouches, suture loops, and uterine manipulators. Products are sold through direct sales to hospitals and channel distributors internationally.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Sejong Medical product offering

Product offering

Core offering

Sejong Medical develops, manufactures, and sells laparoscopic surgical instruments for minimally invasive surgery, including trocars (Laport series), single-port access systems (Lapsingle), specimen retrieval pouches (Lapbag, Dropbag), suture loops (Laploop), suction/irrigation electrodes (LAP-iX), smoke filters (Smoklean), and uterine manipulators (BUMI). All products are manufactured in-house through a 100% one-stop production system covering R&D, manufacturing, packaging, and sterilization, and are sold to hospitals, surgical centers, and international distributors.

Product overview

Sejong Medical is a Korean medical device company specializing in laparoscopic surgical instruments, established in 1996 and recognized as a leader in Korea's laparoscopic medical device market. The company operates a One Stop production system covering in-house development, manufacturing, packaging, and sterilization. The product portfolio centers on laparoscopic surgery equipment organized into six main categories: Trocars (Laport series including Laport-S, Laport-U, Laport-MU, Laport-e, Laport-3, DRG Port, Hiport, Mini Port, and Laport-CS for thoracoscopy), Single Port Access Devices (Lapsingle, Lapsingle Plus, Lapsingle Vision, Lapsingle SP for Da Vinci robotic surgery, Search Port, and Wound Retractor), Specimen Retrieval Pouches (Lapbag and Dropbag), Suture Loop Devices (Laploop), Suction Irrigation Electrode Devices (LAP-iX series including LAP-iX2), and Smoke Filters (Smoklean). Additional specialized products include BUMI for uterine manipulation during hysterectomy. The company exports globally and holds international certifications including FDA, CE, ISO 13485, and Korean GMP.

Differentiator

Problem solved

Functional benefit

Brands

  • Laport: Disposable trocar product line including Laport-S, Laport-U, Laport-MU, Laport-e, Laport-3, Laport-CS models
  • Lapsingle
  • Lapbag
  • Dropbag
  • Laploop
  • LAP-iX
  • Smoklean
  • BUMI

Products and services

  • Laport-S A trocar device that maintains pneumoperitoneum and enables insertion of various laparoscopic surgical instruments through the abdominal wall. Features a rotatable 5mm converter for dual-spec use, one-touch button for smoke and gauze removal, serration structure preventing insertion device detachment, and blade-type secondary puncture prevention. Used by surgeons performing laparoscopic surgery.
  • Laport-U (Universal) Universal trocar allowing insertion of various-sized instruments. Features blade-type stable locking mechanism preventing secondary puncture and round head structure for comfortable grip. Used by surgeons performing laparoscopic surgery.
  • Laport-MU (Mini Universal) Mini universal trocar with safety lock and auto loading for secondary puncture prevention. Accommodates instruments from 5mm to 12mm. Features detachable head for easy gauze and specimen removal, serration structure preventing detachment, and 30% smaller head than standard Laport for improved grip and reduced port interference. Used by surgeons performing laparoscopic surgery.
  • DRG Port Trocar with manual locking and release mechanism with indicator. Features 40% smaller simplified head design compared to previous models and cross-shaped sealing valve. Used by surgeons performing laparoscopic surgery.
  • Laport-e Trocar featuring ergonomic design that provides excellent grip comfort for surgeons during laparoscopic surgery.
  • Hiport Trocar equipped with rotatable 5mm converter for dual-spec use. Used by surgeons performing laparoscopic surgery.
  • Mini Port Small-sized trocar designed for pediatric or petite patients requiring smaller instrumentation. Used by surgeons performing laparoscopic surgery.
  • Laport-3 Trocar made of high-durability stainless steel, designed for 2–3mm instruments with minimized body and outer surface providing excellent grip. Used by surgeons performing laparoscopic surgery.
  • Laport-CS Trocar consisting of cannula and stylet for thoracic endoscopic surgery. Features serrated cannula for easy insertion and increased port stability with reduced slippage. Available in Hard Type for strong impact resistance and Soft Type with flexible material reducing tissue and chest pressure. Used by surgeons performing thoracoscopic surgery.
  • Lapsingle Versatile single port for all types of single-port laparoscopic surgery including robotic surgery. Features separable single-port design for single incision surgery, universal port accommodating instruments from 5mm to 12mm, and spring valve ensuring smooth gas circulation. Used by surgeons performing single-incision laparoscopic surgery.
  • Lapsingle Plus Single port device with spring valve for smooth gas circulation and optimized for robotic surgery with high flexibility and heat resistance. Used by surgeons performing robotic-assisted laparoscopic surgery.
  • Lapsingle Vision Single port device with high transparency for enhanced visualization during laparoscopic procedures. Used by surgeons performing single-port laparoscopic surgery.
  • Lapsingle SP Da Vinci robotic surgery single-port laparoscopic device featuring Davinci SP Port (25mm) with transparent material for easy abdominal access. Used by surgeons performing Da Vinci robotic-assisted surgery.
  • Search Port Port primarily used during laparoscopic examination, featuring flexible material allowing easy scope manipulation through the port. Used by surgeons during laparoscopic examination procedures.
  • Wound Retractor Device serving as passage for Lapsingle products, used to protect skin and facilitate easier incision opening. Features high durability of urethane material and provides easy and stable incision space. Used by surgeons performing single-port laparoscopic surgery.
  • Lapbag Specialized bag for safely extracting various specimen tissues generated during laparoscopic surgery. Features automatic pouch operation, multiple sizes (XS, S, M, L, XL, XXL, 3XL), multiple types (U Type, V Type, Y Type), and sturdy durability. Used by surgeons performing laparoscopic surgery.
  • Dropbag Easy-opening specimen retrieval pouch with pre-folded design for easy handling. Features tear-resistant sturdy material pouch and dual welt cores preventing separation of pouch fixation device. Used by surgeons performing laparoscopic surgery.
  • Laploop Device for suturing wounds with convenient usage method. Features absorbable suture material that is harmless to the body and stable knot that does not come undone. Used by surgeons performing wound closure during laparoscopic surgery.
  • LAP-iX S/I only Suction and irrigation device for laparoscopic surgery with shaft size of 5mm and shaft lengths of 330mm and 450mm. Used by surgeons performing laparoscopic surgery.
  • LAP-iX Suction and irrigation device with electrode for various uses during laparoscopic surgery. Features 5mm shaft, separable tip and handle design. Used by surgeons performing laparoscopic surgery.
  • LAP-iX2 Improved suction and irrigation device with electrode featuring enhanced electrode tip that reduces likelihood of carbonized material adhering to end and easier removal. Features ergonomic handle with anti-slip bushing for excellent grip and smooth S/I control with soft button minimizing user fatigue. Used by surgeons performing laparoscopic surgery.
  • Smoklean Filter device that removes harmful particles and substances from exhaust gas generated when using energy devices during laparoscopic surgery. Effectively reduces smoke and color. Features PRE/ACF/DNA filters that filter out carcinogens and smoke. Used by surgical teams during laparoscopic surgery to filter surgical smoke.
  • BUMI Device used during laparoscopic hysterectomy to adjust uterine position. Features ergonomic handle for user comfort during long surgeries, automatic valve preventing air leakage after inflation, tip with surgical cutting guide line and rotatable handle for cup angle adjustment, and 1mm thick round tip providing sufficient strength. Used by gynecologic surgeons performing laparoscopic hysterectomy.

Quantifiable outcome

  • Laparoscopic surgery reduces recovery time to 5–10 days compared to 6–8 weeks for open surgery
  • +2 more outcomes

Companies that use Sejong Medical

Customer profile

Segments2 records

Ideal customer profiles2 records

Sejong Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Sejong Medical partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • 삼정회계법인 Deal Advisory (Samil KPMG)coreImplementation/ SI/ Consulting Partner · 1 October 2025KPMG Korea's Deal Advisory division (Samil) served as M&A advisor and sale process manager for the competitive tender sale of BSJ Holdings' stake in Sejong Medical. Managing directors Bong-soo Kim and Se-hun Kim oversaw the process, managing bidder qualification, due diligence data rooms, and bidding coordination.
  • Local Distributors (International)coreChannel Partner/ Reseller/ DistributorSejong Medical forms strategic partnerships with local distributors in overseas markets to expand its global footprint. These distributors facilitate local market entry, regulatory navigation, and sales distribution for Sejong's laparoscopic devices across multiple international markets.
  • Medical Institutions (International)minorStrategic or Co-development PartnerSejong Medical collaborates with international medical institutions to support product adoption, gather clinical feedback, and tailor products to regional medical practices and surgical technique requirements.

Scale indicators4 records

Recent moves8 records

Expansion highlights4 records

Sejong Medical competitors and assessment

Company assessment

Broad incumbents

  • B. Braun Melsungen AG:
  • Ethicon (Johnson & Johnson MedTech): Ethicon is the surgical instruments arm of Johnson & Johnson and a dominant global supplier of trocars, staplers, sutures, and other laparoscopic devices. Operates broadly across all surgical specialties served by Sejong, with vastly larger scale.
  • Medtronic (Minimally Invasive Therapies): Medtronic's Minimally Invasive Therapies group (including legacy Covidien) is a leading global supplier of laparoscopic instruments, energy devices, and surgical supplies. Broad incumbent with substantial overlap with Sejong's product categories.
  • Olympus Corporation: Olympus is a global leader in endoscopic visualization and minimally invasive surgical instruments. While strongest in scopes, Olympus also supplies trocars and laparoscopic accessories that overlap with Sejong's portfolio.

Direct peers

  • Karl Storz SE & Co. KG: Karl Storz is a leading German manufacturer of endoscopes and laparoscopic instruments for minimally invasive surgery. Direct competitor to Sejong across the laparoscopic instrument category, with global distribution overlap including Europe and the Middle East.
  • Applied Medical: Applied Medical is a US-based privately held manufacturer of surgical devices including trocars, single-port access systems, and other laparoscopic instruments — directly overlapping Sejong Medical's core trocar (Laport) and single-port (Lapsingle) product lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Sejong Medical social profiles

Digital presence

Sejong Medical compliance and trust

Trust signal

Compliance4 records

Sejong Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sejong Medical leadership team

Management profile

Number of profiles

Profiles1 record

Sejong Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sejong Medical M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sejong Medical

What does Sejong Medical do?

Sejong Medical develops, manufactures, and sells laparoscopic surgical instruments for minimally invasive surgery, including trocars (Laport series), single-port access systems (Lapsingle), specimen retrieval pouches (Lapbag, Dropbag), suture loops (Laploop), suction/irrigation electrodes (LAP-iX), smoke filters (Smoklean), and uterine manipulators (BUMI). All products are manufactured in-house through a 100% one-stop production system covering R&D, manufacturing, packaging, and sterilization, and are sold to hospitals, surgical centers, and international distributors.

Is Sejong Medical a public or private company?

Sejong Medical is a public company. It is classified as public and is currently operating.

When was Sejong Medical founded?

Sejong Medical was founded in 1996. It employs 101 to 250 people.

Where is Sejong Medical based?

Sejong Medical is headquartered in Paju, South Korea, in the Asia region.

How does Sejong Medical make money?

One revenue line is on record: medical Device Sales.

Who are Sejong Medical's main competitors?

Broad incumbents on record are B. Braun Melsungen AG, Ethicon (Johnson & Johnson MedTech), Medtronic (Minimally Invasive Therapies) and Olympus Corporation. Direct peers are Karl Storz SE & Co. KG and Applied Medical.

Does Sejong Medical have an API?

No public API is recorded for Sejong Medical.

What industry is Sejong Medical in?

Sejong Medical's product category is Laparoscopic Surgical Instruments / Minimally Invasive Surgery Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nate[Sejong Medical Mystery] Continued Investment Failures, There is Someone Who is Smiling: Nate NewsSejong Medical is facing delisting after a court lawsuit to suspend the decision, with an accumulated deficit of 154.8 billion won. The company suffered investment losses near 100 billion won, including a failed Genensel investment and a Canaria Bio acquisition that yielded only 10 billion won from 50 billion won in shares.Nate'Kim Seung-won lobby suspicion' Genensel, the forces that made a profit in 2020 are working again in 2021... suspicion of using undisclosed information: Nate NewsInvestors who profited from Genensel-related stocks in 2020 also made gains in 2021, with some selling shares after Genensel received domestic clinical trial approval. Time Investment, which acquired Genensel via Sejong Medical, sold shares at about 5,000 won per share, estimated to yield at least a 25% profit. The timing raises suspicion of using undisclosed information.NateJust before receiving 600 million from Genensel, 5 people were selected... Kim Seung-won, the new drug broker's 'suspicious hiring': Nate NewsKim Seung-won, a drug broker, is accused of influencing Genensel's clinical approval and receiving 600 million won from the company. The transfer occurred after Genensel received 11.3 billion won from Sejong Medical, and five people were hired at his cosmetics firm to create a corporate appearance.NateInvestors affected by Genensel who visited the National Assembly: 'We need to confirm Kim Seung-won's role' : Nate NewsGenensel investment victims held a press conference at the National Assembly, demanding confirmation of roles played by Genensel founder Kang Se-chan, broker Yang Mo, and candidate Kim Seung-won. They cited 30,000 Sejong Medical shareholders with estimated damage of about 5 billion won, and asked for disclosure of accurate information and who gained economic benefits.Nate[Exclusive] Broker 'Said to be Sejong Medical, 100 million'... Acquaintance 'Also boasting about connections': Nate NewsA broker, Mr. Yang, received 100 million won from Genensel founder Mr. Kang for requesting approval of a COVID-19 clinical trial from candidate Kim Seung-won. He encouraged acquaintances to buy Sejong Medical stocks, but the trial was later suspended due to a false report, causing losses and a delisting crisis. Sejong Medical sued Kang for 8 billion won in unjust profits.BiospectatorSejong Medical invests 11.3 billion in Genensel.. 'As the largest shareholder'Sejong Medical acquired a 14.01% stake in Genensel for approximately 6.3 billion won and invested an additional 5 billion won in convertible bonds, becoming the company's largest shareholder. The investment is intended to support Genensel’s clinical trials for COVID-19 and shingles treatments while facilitating business diversification for Sejong Medical. Both companies plan to collaborate on licensing and management systems to accelerate development.